| 000 | 01451 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515201002.0 | ||
| 264 | 0 | _c20101022 | |
| 008 | 201010s 0 0 eng d | ||
| 022 | _a1528-1167 | ||
| 024 | 7 |
_a10.1111/j.1528-1167.2009.02412.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChang, Pishan | |
| 245 | 0 | 0 |
_aInhibition of long-term potentiation by valproic acid through modulation of cyclic AMP. _h[electronic resource] |
| 260 |
_bEpilepsia _cAug 2010 |
||
| 300 |
_a1533-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticonvulsants _xpharmacology |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
| 650 | 0 | 4 |
_aCyclic AMP-Dependent Protein Kinases _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aEpilepsy _xdrug therapy |
| 650 | 0 | 4 |
_aIsoquinolines _xpharmacology |
| 650 | 0 | 4 |
_aLong-Term Potentiation _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 650 | 0 | 4 |
_aValproic Acid _xpharmacology |
| 700 | 1 | _aChandler, Kate E | |
| 700 | 1 | _aWilliams, Robin S B | |
| 700 | 1 | _aWalker, Matthew C | |
| 773 | 0 |
_tEpilepsia _gvol. 51 _gno. 8 _gp. 1533-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1528-1167.2009.02412.x _zAvailable from publisher's website |
| 999 |
_c19384357 _d19384357 |
||